For consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.

| Title | Content Type | Date | Description |
|---|---|---|---|
| Varenicline (Champix) for smoking cessation | Professional publication - NPS RADAR - Review | 2011-08-01 00:00:00 | New PBS listing for extension to treatment. Smokers who are abstinent at 12 weeks after starting varenicline can now receive a further 12 weeks of treatment to improve their chance of longer-term abstinence. |
| Varenicline (Champix) — new PBS listing for extra 12 weeks of therapy | Professional publication - NPS RADAR - Brief item | 2011-02-01 00:00:00 | From 1 February 2011, under a new authority listing, varenicline (Champix) can be prescribed for a further 12 weeks for people who respond to an initial 12 weeks of varenicline and who are enrolled in a support and counselling program, as an aid to remaining abstinent. |
| Assessing nicotine dependence | Professional publication - NPS RADAR - Web only item | 2011-02-01 00:00:00 | Nicotine dependence is likely when the patient smokes within 30 minutes of waking, or smokes more than 10 cigarettes per day, or has a history of withdrawal symptoms during previous quit attempts. |
| Varenicline (Champix) safety update: serious neuropsychiatric and dermatological adverse events | Professional publication - NPS RADAR - Brief item | 2009-12-01 00:00:00 | Serious neuropsychiatric symptoms and severe skin reactions have been reported in people taking varenicline. Updated advice on managing neuropsychiatric symptoms and a precaution about rare but potentially fatal skin reactions have been added to the product information. |
| Nicotine patches for Aboriginal and Torres Strait Islander people | Professional publication - NPS RADAR - Brief item | 2008-12-01 00:00:00 | Nicotine patches (Nicorette,15 mg per 16 hours) were authority listed on 1 December 2008 for nicotine dependence in Aboriginal and Torres Strait Islander people. This is the only nicotine replacement therapy subsidised for people who identify as Aboriginal and Torres Strait Islanders. The listing is part of the 2004–05 Budget measure to improve access to medicines for Aboriginal and Torres Strait Islander people. |

NPS RADAR: independent, evidence-based assessment of new drugs, new PBS listings and the latest research for doctors, pharmacists and other health professionals.
Date published: 2009-10-28 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.